| Feb. 2, 2012 | 2-3:30 p.m. | 
J. Donald Easton, MD, FAHA
University of California San Francisco, San Francisco, CA | ARISTOTLE
Apixaban Compared with Warfarin in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
|
|
Nils Wahlgren, MD, PhD
Karolinska, Stockholm, Sweden | TREVOFinal Results From The Trevo Study (Thrombectomy REvascularization of large Vessel Occlusions in acute ischemic stroke) |
|
Michael D. Hill, MD, MSc
University of Calgary, Calgary, AB, Canada | ENACT
Evaluating Neuroprotection in Aneurysm Coiling Therapy Trial Final Results
|
|
Kristina D. Hougaard
Dept. of Neurology, Aarhus University Hospital,
Aarhus, Denmark | Remote Ischemic Perconditioning In Acute Stroke: An Endogenous Model To Generate Neuroprotection. |
|
Helmi L. Lutsep, MD
Oregon Stroke Center OHSU, Portland, OR | SAMMPRISOutcome of Patients in the SAMMPRIS Trial Who Had Failed Antithrombotic Therapy at Study Enrollment |
|
|
Jennifer F. Iaci
Acorda Therapeutics, Inc., Hawthorne, NY | Dalfampridine Improves Sensorimotor Function in Rats with Chronic Deficits Following Middle Cerebral Artery Occulsion |
|
Daniel F. Hanley, MD, FAHA
JOHNS HOPKINS University, Baltimore, MD | MISTIE Phase II ResultsSafety, Efficacy and Surgical Performance |
|
| Feb. 3, 2012 | 11:30 a.m.-1 p.m. | 
Jeffrey L. Saver, MD, FAHA
Geffen School of Medicine at UCLA, Los Angeles, CA | SWIFT
Primary Results of the SOLITAIRE™; With the Intention for Thrombectomy (SWIFT) Multicenter, Randomized Clinical Trial |
|
Oscar Benavente, MD
University of British Columbia, Vancouver, BC, Canada | SPS3
The Secondary Prevention of Small Subcortical Strokes Trial: Results of the Antiplatelet Intervention |
|
E. Bernd Ringelstein,
MD, FAHA
Neurolgy, Univ Münster, Münster, Germany | AXIS-2
AX200 for the Treatment of Acute Ischemic Stroke |
|
Joseph P. Broderick,
MD, FAHA
University of Cincinnati, Cincinnati, OH | WES in FIA
Whole Exome Sequencing in Familial Intracranial Aneurysm: Initial Findings |
|
Shunichi Homma, MD
Columbia University Medical Center, New York, NY | WARCEFResults of the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial |
|
|
